The sponsor shall inform the National Commission for Research Involving the Human Person and the National Agency for the Safety of Medicines and Health Products without delay of situations in which it has terminated the participation of an investigator or any other person involved in the research because of a serious or deliberately repeated deviation from the protocol, or a serious breach of the legislative and regulatory provisions in force or of the good practices provided for in Article L. 1121-3 which are likely to compromise the safety of the persons taking part in this research or the reliability of the data from this research.